Robin Carhart-Harris

Dr. Robin Carhart-Harris is the Founding Director of the Neuroscape Psychedelics Division at UCSF.

Previously he held the director role at Imperial College London, where he has designed a number of functional brain imaging studies with psilocybin (magic mushrooms), LSD, MDMA (ecstasy) and DMT (ayahuasca), plus clinical trials of psilocybin for treatment-resistant depression. His scientific contributions to psychedelic-assisted therapy could play a significant role in the future of psychedelics for mental health care.

CV of Robin Carhart-Harris

Robin Carhart-Harris got his PhD at the University of Bristol (2009) and has worked at Imperial College London since then. When the Centre for Psychedelic Research was founded, he became its director.

He was listed in the TIME100 NEXT list (2021) as one of the innovators.

He is a member of the (scientific) advisory board of Synthesis, MIND Foundation, Mydecine, Compass Pathways, Beckley Psytech, Entheon, Tryp Therapeutics, Qualia Research Institute, Journey Colab, Osmind, and Fireside Project.

Since 2021 he is the founding director of the Neuroscape Psychedelics Division at the University of California, San Francisco (UCSF).

Media

He has given many talks:

More media:

Explore more info with a membership (any level)

🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)

Explore memberships